ferrous gluconate has been researched along with zidovudine in 1 studies
| Studies (ferrous gluconate) | Trials (ferrous gluconate) | Recent Studies (post-2010) (ferrous gluconate) | Studies (zidovudine) | Trials (zidovudine) | Recent Studies (post-2010) (zidovudine) |
|---|---|---|---|---|---|
| 92 | 31 | 25 | 10,180 | 1,399 | 1,188 |
| Protein | Taxonomy | ferrous gluconate (IC50) | zidovudine (IC50) |
|---|---|---|---|
| Thymidine kinase, cytosolic | Homo sapiens (human) | 3 | |
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 0.6633 | |
| Protease | Human immunodeficiency virus 1 | 0.015 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, YA; Saxena, BB; Singh, M | 1 |
1 other study(ies) available for ferrous gluconate and zidovudine
| Article | Year |
|---|---|
Development of vaginal rings for sustained release of nonhormonal contraceptives and anti-HIV agents.
Topics: Anti-HIV Agents; Ascorbic Acid; Cervix Mucus; Contraceptive Agents, Female; Contraceptive Devices, Female; Drug Delivery Systems; Female; Ferrous Compounds; Gum Arabic; Humans; Hydrogen-Ion Concentration; Male; Methacrylates; Spermatozoa; Zidovudine | 2007 |